BMRN — BioMarin Pharmaceutical Share News
0.000.00%
Last trade - 00:00- $10.85bn
- $14.16bn
- $3.22bn
BioMarin rises after Oppenheimer upgrades on revenue growth prospects
U.S. STOCKS ON THE MOVE-Repligen, Mangoceuticals, Insmed
U.S. STOCKS ON THE MOVE-Sabre, MicroStrategy, Repligen
U.S. STOCKS ON THE MOVE-Roku, BioMarin, Assurant
U.S. STOCKS ON THE MOVE-Roku, BioMarin, Amplitude
BioMarin rises after Q4 results beat estimates
BioMarin Pharmaceutical Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Biomarin Pharmaceutical Q4 EPS USD 0.64
Brief: Biomarin Announces Legal Action Against Ascendis Pharma A/S In European Unified Patent Court
U.S. STOCKS ON THE MOVE-Cruise stocks, US airline stocks
Gene therapy makers set to end 2024 in the red
U.S. RESEARCH ROUNDUP-Cigna, Marriott, Ralph Lauren
U.S. RESEARCH ROUNDUP- Alphabet, Arthur J. Gallagher & Co, Leggett & Platt
BioMarin Pharmaceutical Inc reports results for the quarter ended in January 1 - Earnings Summary
Brief: Biomarin Pharmaceutical Q3 EPS USD 0.55
US FDA approves Pfizer's drug for rare bleeding disorder
Brief: Biomarin Pharmaceutical Inc Reaffirming Its Long-Term Financial Guidance And Outlook That It Presented During Investor Day
Ascendis Pharma slips after $300 mln share offering launch
U.S. RESEARCH ROUNDUP- Aerovironment, Insulet, Viasat